These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 2441854

  • 1. Heterogeneity of circulating carcinoembryonic antigen analyzed by sandwich-enzyme immunoassays with different specificities.
    Suzuki N, Kondo K, Tominaga S, Kuroki M, Matsuoka Y.
    Cancer Res; 1987 Sep 15; 47(18):4782-7. PubMed ID: 2441854
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M, Kuroki M, Koga Y, Matsuoka Y.
    J Immunol; 1984 Oct 15; 133(4):2090-7. PubMed ID: 6206151
    [Abstract] [Full Text] [Related]

  • 3. Antigenic heterogeneity of carcinoembryonic antigen in the circulation defined by monoclonal antibodies against the carbohydrate moiety of carcinoembryonic antigen and closely related antigens.
    Matsunaga A, Kuroki M, Higuchi H, Arakawa F, Takakura K, Okamoto N, Matsuoka Y.
    Cancer Res; 1987 Jan 01; 47(1):56-61. PubMed ID: 2431767
    [Abstract] [Full Text] [Related]

  • 4. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.
    Matsuoka Y, Kuroki M, Koga Y, Kuriyama H, Mori T, Kosaki G.
    Cancer Res; 1982 May 01; 42(5):2012-8. PubMed ID: 6175402
    [Abstract] [Full Text] [Related]

  • 5. Antigenic variants of the nonspecific cross-reacting antigen (NCA).
    Burtin P, Chavanel G, Hendrick JC, Frenoy N.
    J Immunol; 1986 Aug 01; 137(3):839-45. PubMed ID: 2424986
    [Abstract] [Full Text] [Related]

  • 6. Epitope mapping of the carcinoembryonic antigen by monoclonal antibodies and establishment of a new improved radioimmunoassay system.
    Kuroki M, Arakawa F, Higuchi H, Matsunaga A, Okamoto N, Takakura K, Matsuoka Y.
    Jpn J Cancer Res; 1987 Apr 01; 78(4):386-96. PubMed ID: 2438262
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay.
    Wagener C, Clark BR, Rickard KJ, Shively JE.
    J Immunol; 1983 May 01; 130(5):2302-7. PubMed ID: 6187848
    [Abstract] [Full Text] [Related]

  • 8. Production kinetics and immunochemical properties of carcinoembryonic antigen and nonspecific cross-reacting antigen synthesized by various human tumor cell lines.
    Ichiki S, Kuroki M, Kuroki M, Koga Y, Matsuoka Y.
    Jpn J Cancer Res; 1986 May 01; 77(5):462-72. PubMed ID: 2426231
    [Abstract] [Full Text] [Related]

  • 9. Nonspecific cross-reacting antigen-50/90 (NCA-50/90) as a new tumor marker.
    Kuroki M, Matsushita H, Matsumoto H, Hirose Y, Senba T, Yamamoto T.
    Anticancer Res; 1999 May 01; 19(6C):5599-606. PubMed ID: 10697625
    [Abstract] [Full Text] [Related]

  • 10. Characterization of carcinoembryonic antigen-specific monoclonal antibodies and specific carcinoembryonic antigen assay in sera of patients.
    Kitagawa H, Ohkouchi E, Fukuda A, Imai K, Yachi A.
    Jpn J Cancer Res; 1986 Sep 01; 77(9):922-30. PubMed ID: 2429946
    [Abstract] [Full Text] [Related]

  • 11. Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human sera.
    Frénoy N, Schauffler J, Cahour A, Burtin P.
    Anticancer Res; 1987 Sep 01; 7(6):1229-33. PubMed ID: 3327450
    [Abstract] [Full Text] [Related]

  • 12. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL, Purnell DM, Combs JW, Hillman EA, Harris CC, Trump BF.
    Cancer Res; 1986 Jun 01; 46(6):2936-43. PubMed ID: 2421889
    [Abstract] [Full Text] [Related]

  • 13. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM, Heatfield BM, Trump BF.
    Cancer Res; 1984 Jan 01; 44(1):285-92. PubMed ID: 6197163
    [Abstract] [Full Text] [Related]

  • 14. Expression of complementary DNA and genomic clones for carcinoembryonic antigen and nonspecific cross-reacting antigen in Chinese hamster ovary and mouse fibroblast cells and characterization of the membrane-expressed products.
    Hefta LJ, Schrewe H, Thompson JA, Oikawa S, Nakazato H, Shively JE.
    Cancer Res; 1990 Apr 15; 50(8):2397-403. PubMed ID: 2317824
    [Abstract] [Full Text] [Related]

  • 15. Identification of a novel tumor-associated Mr 110,000 gene product in human gastric carcinoma cells that is immunologically related to carcinoembryonic antigen.
    Shimada S, Ogawa M, Schlom J, Greiner JW.
    Cancer Res; 1991 Oct 15; 51(20):5694-703. PubMed ID: 1913687
    [Abstract] [Full Text] [Related]

  • 16. Coproduction of carcinoembryonic antigen and nonspecific cross-reacting antigen by a continuous cell line from a human pancreatic tumor.
    Kuroki M, Ichiki S, Kuroki M, Matsuoka Y.
    J Natl Cancer Inst; 1982 Aug 15; 69(2):401-8. PubMed ID: 6810002
    [Abstract] [Full Text] [Related]

  • 17. Immunological heterogeneity of carcinoembryonic antigen: antigenic determinants on carcinoembryonic antigen distinguished by monoclonal antibodies.
    Primus FJ, Newell KD, Blue A, Goldenberg DM.
    Cancer Res; 1983 Feb 15; 43(2):686-92. PubMed ID: 6184152
    [Abstract] [Full Text] [Related]

  • 18. [Antigenic structures of CEA and CEA-related normal antigens and problems related to the determination of blood CEA concentrations].
    Matsuoka Y, Kuroki M, Koga Y.
    Gan To Kagaku Ryoho; 1983 Feb 15; 10(2 Pt 2):575-84. PubMed ID: 6192762
    [Abstract] [Full Text] [Related]

  • 19. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
    Allard WJ, Neaman IE, Elting JJ, Barnett TR, Yoshimura H, Fritsche HA, Yeung KK.
    Cancer Res; 1994 Mar 01; 54(5):1227-34. PubMed ID: 8118811
    [Abstract] [Full Text] [Related]

  • 20. CEA-specificity of CEA-reactive monoclonal antibodies. Immunochemical and immunocytochemical studies.
    Verstijnen CP, Arends JW, Moerkerk PT, Warnaar S, Hilgers J, Bosman FT.
    Anticancer Res; 1986 Mar 01; 6(1):97-104. PubMed ID: 2420267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.